184: Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)

M. Alsina; T. Alekshun; C. McIsaac-Simonelli; M. Kharfan-Dabaja; W. Dalton; B. Djulbegovic; H. Fernandez; D.M. Sullivan; E. Ayala; T. Field; D. Garrett; W.E. Janssen; B. Maddox; L.E. Perez; D. Kettner; J. Perkins; J. Raychaudhuri; C.H. Anasetti

doi:10.1016/j.bbmt.2007.12.193

184: Phase I Study of Bortezomib, (BTZ) followed by High-Dose Melphalan, (HD Mel) and BTZ as Conditioning Regimen for Tandem Peripheral Blood Stem Cell Transplants (TanPSCT) in Patients with Primary Refractory Multiple Myeloma (MM) and Plasma Cell Leukemia (PCL)

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2007.12.193 ◽

2008 ◽

Vol 14 (2) ◽

pp. 68

Author(s):

M. Alsina ◽

T. Alekshun ◽

C. McIsaac-Simonelli ◽

M. Kharfan-Dabaja ◽

W. Dalton ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Phase I Study ◽

Peripheral Blood Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

Cell Leukemia ◽

Cell Transplants ◽

High Dose Melphalan

Download Full-text

A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Leukemia ◽

10.1038/sj.leu.2403575 ◽

2004 ◽

Vol 19 (1) ◽

pp. 118-125 ◽

Cited By ~ 31

Author(s):

A Dispenzieri ◽

G A Wiseman ◽

M Q Lacy ◽

M R Litzow ◽

P M Anderson ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Peripheral Blood ◽

Phase I Study ◽

Peripheral Blood Stem Cell ◽

Conditioning Regimen ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan

Download Full-text

A Phase I/II Study of Escalating Doses of Bortezomib in Conjunction with High-Dose Melphalan as a Conditioning Regimen for Salvage Autologous Peripheral Blood Stem Cell Transplantation in Patients with Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.08.017 ◽

2016 ◽

Vol 22 (12) ◽

pp. 2165-2171 ◽

Cited By ~ 9

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Phase I ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan ◽

Blood Stem Cell Transplantation

Download Full-text

Bortezomib Followed by a Phase I Study of Bortezomib in Combination With High-Dose Melphalan as a Preparative Regimen for Hematopoietic Cell Transplants in Patients With Primary Refractory Multiple Myeloma or Plasma Cell Leukemia

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2010.12.150 ◽

2011 ◽

Vol 17 (2) ◽

pp. S200-S201 ◽

Cited By ~ 2

Author(s):

T. Nishihori ◽

T.J. Alekshun ◽

D.M. Sullivan ◽

M.A. Kharfan-Dabaja ◽

J. Raychaudhuri ◽

...

Keyword(s):

Multiple Myeloma ◽

Phase I ◽

Plasma Cell ◽

Phase I Study ◽

Hematopoietic Cell ◽

High Dose ◽

Cell Leukemia ◽

Cell Transplants ◽

Preparative Regimen ◽

High Dose Melphalan

Download Full-text

A phase I/II study of escalating doses of thalidomide in conjunction with bortezomib and high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/s41409-019-0534-0 ◽

2019 ◽

Vol 54 (11) ◽

pp. 1881-1891

Author(s):

Noa Biran ◽

Scott D. Rowley ◽

David H. Vesole ◽

Shijia Zhang ◽

Michele L. Donato ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Phase I ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan

Download Full-text

A Phase II study of153Sm-EDTMP and high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

American Journal of Hematology ◽

10.1002/ajh.21696 ◽

2010 ◽

pp. NA-NA

Author(s):

Angela Dispenzieri ◽

Gregory A. Wiseman ◽

Martha Q. Lacy ◽

Suzanne R. Hayman ◽

Shaji K. Kumar ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Phase Ii Study ◽

Conditioning Regimen ◽

Blood Stem Cell ◽

High Dose ◽

High Dose Melphalan

Download Full-text

Aprepitant for the control of delayed nausea and vomiting associated with the use of high-dose melphalan for autologous peripheral blood stem cell transplants in patients with multiple myeloma: a phase II study

Supportive Care in Cancer ◽

10.1007/s00520-014-2248-6 ◽

2014 ◽

Vol 22 (11) ◽

pp. 2911-2916 ◽

Cited By ~ 11

Author(s):

Thomas Bechtel ◽

Ali McBride ◽

Brooke Crawford ◽

Susan Bullington ◽

Craig C. Hofmeister ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase Ii ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Phase Ii Study ◽

High Dose ◽

Delayed Nausea ◽

Cell Transplants ◽

High Dose Melphalan

Download Full-text

Phase I–II evaluation of rapid sequence tandem high-dose melphalan with peripheral blood stem cell support in patients with multiple myeloma

Bone Marrow Transplantation ◽

10.1038/sj.bmt.1701324 ◽

1998 ◽

Vol 22 (3) ◽

pp. 245-251 ◽

Cited By ~ 23

Author(s):

CH Weaver ◽

B Zhen ◽

LS Schwartzberg ◽

R Leff ◽

M Magee ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

High Dose ◽

Stem Cell Support ◽

Rapid Sequence ◽

High Dose Melphalan ◽

Cell Support

Download Full-text

Combination of high-dose melphalan and bortezomib as conditioning regimen for autologous peripheral blood stem cell transplantation in multiple myeloma

International Journal of Hematology ◽

10.1007/s12185-013-1402-0 ◽

2013 ◽

Vol 98 (3) ◽

pp. 337-345 ◽

Cited By ~ 16

Author(s):

Toshihiro Miyamoto ◽

Goichi Yoshimoto ◽

Tomohiko Kamimura ◽

Tsuyoshi Muta ◽

Shuichiro Takashima ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Peripheral Blood ◽

Peripheral Blood Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

High Dose Melphalan ◽

Blood Stem Cell Transplantation

Download Full-text

A phase i study of high-dose melphalan + topotecan + VP-16 phosphate (Mtv) Followed by autologous stem cell rescue in multiple myeloma

Experimental Hematology ◽

10.1016/s0301-472x(00)00428-8 ◽

2000 ◽

Vol 28 (7) ◽

pp. 110 ◽

Cited By ~ 1

Author(s):

D. Sullivan ◽

W. Dalton ◽

R. Djulbegovic ◽

K. Fields ◽

T. Field ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Phase I ◽

Phase I Study ◽

High Dose ◽

Stem Cell Rescue ◽

Autologous Stem Cell Rescue ◽

High Dose Melphalan

Download Full-text

Busulfan, Melphalan, and Bortezomib versus High-Dose Melphalan as a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2016.03.021 ◽

2016 ◽

Vol 22 (8) ◽

pp. 1391-1396 ◽

Cited By ~ 19

Author(s):

Tulio E. Rodriguez ◽

Parameswaran Hari ◽

Patrick J. Stiff ◽

Scott E. Smith ◽

Danielle Sterrenberg ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Hematopoietic Stem Cell Transplantation ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Hematopoietic Stem Cell ◽

Conditioning Regimen ◽

High Dose ◽

Hematopoietic Stem ◽

High Dose Melphalan

Download Full-text